Melanie Marshall
Chief Tech/Sci/R&D Officer at OSSDSIGN AB
Profile
Melanie Marshall is currently working as the Vice President-Clinical & Medical Affairs at OssDsign AB since 2022.
Prior to this, she worked as the Vice President-Clinical Operations at ApaTech Ltd.
Ms. Marshall completed her undergraduate degree from Wheaton College (Massachusetts).
Melanie Marshall active positions
| Companies | Position | Start |
|---|---|---|
| OSSDSIGN AB | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Former positions of Melanie Marshall
| Companies | Position | End |
|---|---|---|
ApaTech Ltd.
 ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Chief Tech/Sci/R&D Officer | - |
Training of Melanie Marshall
| Wheaton College (Massachusetts) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OSSDSIGN AB | Health Technology |
| Private companies | 1 |
|---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
- Stock Market
- Insiders
- Melanie Marshall
